Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Chemotherapy (FLOT) vs Neoadjuvant Chemoradiation (CROSS) in Esophageal Adenocarcinoma
DRKS00008008Phase 3Completed
- Sponsor
- University Hospital Schleswig-Holstein
- Start
- Sep 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of docetaxel, oxaliplatin, fluorouracil, folinic acid, carboplatin and 1 more in esophageal adenocarcinoma (EAC) and Esophago-Gastric Adenocarcinoma (2 arms), sponsored by University Hospital Schleswig-Holstein. Started Sep 2015; status: completed.
02
Drugs
docetaxeloxaliplatinfluorouracilfolinic acidcarboplatin
03
Conditions
esophageal adenocarcinoma (EAC)Esophago-Gastric Adenocarcinoma
Beyond the preview
Go deeper on DRKS00008008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00008008.